Latest filing published 22 Dec 2025 for CITIUS ONCOLOGY, INC..
No signal scores available.
Myron Z. Holubiak has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Citius Pharmaceuticals, Inc., Citius Oncology, Inc. and Option Care Health, Inc. Over a trading history stretching from 30 March 2016 to 19 September 2025, the count stands at 11 filings.
Purchases make up the whole of the open-market record (4 purchases, €1.5M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 1 option exercise.
The median purchase comes to €318k. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The latest filing, published on 22 December 2025, reports a share grant in Citius Oncology, Inc. The most recent open-market purchase was published on 27 September 2019, 2,583 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations